Zimmer Biomet Holdings Debt to Equity Ratio 2012-2026 | ZBH
Current and historical debt to equity ratio values for Zimmer Biomet Holdings (ZBH) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Zimmer Biomet Holdings debt/equity for the three months ending June 30, 2026 was 0.50.
| Zimmer Biomet Holdings Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2026-06-30 | $10.17B | $12.63B | 0.81 |
| 2026-03-31 | $10.04B | $12.68B | 0.79 |
| 2025-12-31 | $10.39B | $12.71B | 0.82 |
| 2025-09-30 | $10.72B | $12.77B | 0.84 |
| 2025-06-30 | $10.33B | $12.53B | 0.82 |
| 2025-03-31 | $9.78B | $12.40B | 0.79 |
| 2024-12-31 | $8.89B | $12.48B | 0.71 |
| 2024-09-30 | $9.34B | $12.38B | 0.75 |
| 2024-06-30 | $8.77B | $12.75B | 0.69 |
| 2024-03-31 | $8.85B | $12.61B | 0.70 |
| 2023-12-31 | $9.01B | $12.49B | 0.72 |
| 2023-09-30 | $8.70B | $12.52B | 0.70 |
| 2023-06-30 | $8.92B | $12.38B | 0.72 |
| 2023-03-31 | $9.09B | $12.16B | 0.75 |
| 2022-12-31 | $9.04B | $12.03B | 0.75 |
| 2022-09-30 | $9.08B | $12.25B | 0.74 |
| 2022-06-30 | $9.33B | $12.13B | 0.77 |
| 2022-03-31 | $9.60B | $12.02B | 0.80 |
| 2021-12-31 | $10.79B | $12.67B | 0.85 |
| 2021-09-30 | $11.29B | $12.71B | 0.89 |
| 2021-06-30 | $11.64B | $12.58B | 0.93 |
| 2021-03-31 | $11.58B | $12.45B | 0.93 |
| 2020-12-31 | $12.22B | $12.20B | 1.00 |
| 2020-09-30 | $12.15B | $11.88B | 1.02 |
| 2020-06-30 | $12.00B | $11.64B | 1.03 |
| 2020-03-31 | $13.63B | $11.88B | 1.15 |
| 2019-12-31 | $12.25B | $12.39B | 0.99 |
| 2019-09-30 | $12.23B | $12.09B | 1.01 |
| 2019-06-30 | $12.54B | $11.66B | 1.08 |
| 2019-03-31 | $12.75B | $11.54B | 1.11 |
| 2018-12-31 | $12.85B | $11.28B | 1.14 |
| 2018-09-30 | $13.16B | $12.22B | 1.08 |
| 2018-06-30 | $13.45B | $12.04B | 1.12 |
| 2018-03-31 | $15.18B | $12.00B | 1.27 |
| 2017-12-31 | $14.28B | $11.74B | 1.22 |
| 2017-09-30 | $15.97B | $10.45B | 1.53 |
| 2017-06-30 | $16.18B | $10.28B | 1.57 |
| 2017-03-31 | $17.05B | $9.93B | 1.72 |
| 2016-12-31 | $17.02B | $9.67B | 1.76 |
| 2016-09-30 | $17.29B | $9.75B | 1.77 |
| 2016-06-30 | $16.42B | $9.55B | 1.72 |
| 2016-03-31 | $16.64B | $9.66B | 1.72 |
| 2015-12-31 | $17.27B | $9.89B | 1.75 |
| 2015-09-30 | $16.70B | $9.99B | 1.67 |
| 2015-06-30 | $17.08B | $10.13B | 1.69 |
| 2015-03-31 | $10.61B | $6.58B | 1.61 |
| 2014-12-31 | $3.11B | $6.55B | 0.47 |
| 2014-09-30 | $3.13B | $6.54B | 0.48 |
| 2014-06-30 | $3.19B | $6.45B | 0.49 |
| 2014-03-31 | $3.14B | $6.24B | 0.50 |
| 2013-12-31 | $3.28B | $6.30B | 0.52 |
| 2013-09-30 | $3.22B | $6.14B | 0.52 |
| 2013-06-30 | $3.21B | $5.89B | 0.55 |
| 2013-03-31 | $3.03B | $5.71B | 0.53 |
| 2012-12-31 | $3.15B | $5.87B | 0.54 |
| 2012-09-30 | $2.95B | $5.83B | 0.51 |
| 2012-06-30 | $2.90B | $5.71B | 0.51 |
| 2012-03-31 | $2.94B | $5.66B | 0.52 |
| 2011-12-31 | $3.00B | $5.52B | 0.54 |
| 2011-09-30 | $2.59B | $5.61B | 0.46 |
| 2011-06-30 | $2.23B | $6.02B | 0.37 |
| 2011-03-31 | $2.25B | $5.86B | 0.38 |
| 2010-12-31 | $2.23B | $5.77B | 0.39 |
| 2010-09-30 | $2.18B | $5.82B | 0.38 |
| 2010-06-30 | $2.09B | $5.74B | 0.37 |
| 2010-03-31 | $2.11B | $5.71B | 0.37 |
| 2009-12-31 | $2.15B | $5.64B | 0.38 |
| 2009-09-30 | $1.67B | $5.98B | 0.28 |
| 2009-06-30 | $1.66B | $5.81B | 0.29 |
| 2009-03-31 | $1.68B | $5.56B | 0.30 |
| 2008-12-31 | $1.59B | $5.65B | 0.28 |
| 2008-09-30 | $1.46B | $5.62B | 0.26 |
| 2008-06-30 | $1.44B | $5.51B | 0.26 |
| 2008-03-31 | $1.21B | $5.71B | 0.21 |
| 2007-12-31 | $1.18B | $5.45B | 0.22 |
| 2007-09-30 | $1.11B | $5.25B | 0.21 |
| 2007-06-30 | $1.04B | $5.28B | 0.20 |
| 2007-03-31 | $0.98B | $5.12B | 0.19 |
| 2006-12-31 | $1.05B | $4.92B | 0.21 |
| 2006-09-30 | $1.11B | $4.80B | 0.23 |
| 2006-06-30 | $1.07B | $4.90B | 0.22 |
| 2006-03-31 | $0.99B | $4.92B | 0.20 |
| 2005-12-31 | $1.04B | $4.68B | 0.22 |
| 2005-09-30 | $1.12B | $4.51B | 0.25 |
| 2005-06-30 | $1.25B | $4.31B | 0.29 |
| 2005-03-31 | $1.44B | $4.15B | 0.35 |
| 2004-12-31 | $1.75B | $3.94B | 0.45 |
| 2004-09-30 | $1.70B | $3.63B | 0.47 |
| 2004-06-30 | $1.82B | $3.49B | 0.52 |
| 2004-03-31 | $1.88B | $3.31B | 0.57 |
| 2003-12-31 | $2.01B | $3.14B | 0.64 |
| 2003-09-30 | $0.50B | $0.75B | 0.67 |
| 2003-06-30 | $0.50B | $0.65B | 0.76 |
| 2003-03-31 | $0.44B | $0.54B | 0.80 |
| 2002-12-31 | $0.49B | $0.37B | 1.35 |
| 2002-09-30 | $0.58B | $0.29B | 2.02 |
| 2002-06-30 | $0.65B | $0.21B | 3.17 |
| 2002-03-31 | $0.66B | $0.13B | 4.90 |
| 2001-12-31 | $0.67B | $0.08B | 8.47 |
| 2001-09-30 | $0.72B | $0.02B | 30.41 |
| 2001-06-30 | $0.40B | $0.25B | 1.62 |
| 2001-03-31 | $0.00B | 0.00 | |
| 2000-09-30 | $0.00B | 0.00 | |
| 2000-06-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $17.977B | $8.232B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $176.897B | 19.43 |
| Medtronic (MDT) | Ireland | $118.666B | 16.22 |
| Stryker (SYK) | United States | $107.450B | 20.08 |
| EssilorLuxottica (ESLOY) | France | $75.078B | 0.00 |
| Boston Scientific (BSX) | United States | $63.114B | 13.57 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.379B | 0.00 |
| Agilent Technologies (A) | United States | $44.077B | 25.80 |
| Medline (MDLN) | United States | $42.228B | 0.00 |
| ResMed (RMD) | United States | $32.950B | 20.45 |
| GE HealthCare Technologies (GEHC) | United States | $29.109B | 13.92 |
| Koninklijke Philips (PHG) | Netherlands | $24.258B | 12.92 |
| Terumo (TRUMY) | Japan | $21.654B | 20.68 |
| Baxter (BAX) | United States | $11.901B | 11.23 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.666B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.225B | 41.21 |
| Demant (WILYY) | Denmark | $10.101B | 0.00 |
| Insulet (PODD) | United States | $9.817B | 24.11 |
| Sunny Optical Technology (SNPTF) | China | $9.508B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.579B | 20.24 |
| BillionToOne (BLLN) | United States | $5.222B | 158.10 |
| Raia Drogasil SA - (RADLY) | Brazil | $5.122B | 0.00 |
| Haemonetics (HAE) | United States | $4.895B | 21.48 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| ICU Medical (ICUI) | United States | $3.822B | 22.82 |
| Envista Holdings (NVST) | United States | $3.805B | 16.12 |
| AtriCure (ATRC) | United States | $3.007B | 257.04 |
| Neogen (NEOG) | United States | $2.798B | 49.35 |
| Curaleaf Holdings (CURLF) | United States | $2.396B | 0.00 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.288B | 0.00 |
| Trulieve Cannabis (TRLV) | United States | $2.243B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.201B | 10.51 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.888B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.871B | 5.39 |
| LeMaitre Vascular (LMAT) | United States | $1.817B | 29.22 |
| BioLife Solutions (BLFS) | United States | $1.803B | 230.31 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.450B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.436B | 15.31 |
| Phibro Animal Health (PAHC) | United States | $1.399B | 10.73 |
| Omeros (OMER) | United States | $1.336B | 6.76 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.107B | 0.00 |
| CeriBell (CBLL) | United States | $0.959B | 0.00 |
| InMode (INMD) | Israel | $0.836B | 11.63 |
| AdaptHealth (AHCO) | United States | $0.785B | 16.46 |
| VAREX IMAGING (VREX) | United States | $0.781B | 17.17 |
| QuidelOrtho (QDEL) | United States | $0.761B | 8.21 |
| Glass House Brands (GLAS) | United States | $0.749B | 0.00 |
| Valneva SE (VALN) | France | $0.623B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.548B | 0.00 |
| Brainsway (BWAY) | Israel | $0.544B | 30.75 |
| Vireo Growth (VREOF) | United States | $0.540B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.537B | 0.00 |
| Cerus (CERS) | United States | $0.536B | 0.00 |
| Evolus (EOLS) | United States | $0.529B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.446B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.367B | 0.00 |
| SNDL (SNDL) | Canada | $0.350B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.341B | 24.86 |
| Sanara MedTech (SMTI) | United States | $0.321B | 159.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.302B | 0.00 |
| MacroGenics (MGNX) | United States | $0.263B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 13.28 |
| OraSure Technologies (OSUR) | United States | $0.241B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.236B | 22.62 |
| High Tide (HITI) | Canada | $0.236B | 53.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.201B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.194B | 0.00 |
| Exagen (XGN) | United States | $0.191B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.151B | 0.00 |
| Quanterix (QTRX) | United States | $0.148B | 0.00 |
| Apyx Medical (APYX) | United States | $0.128B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.091B | 124.75 |
| FitLife Brands (FTLF) | United States | $0.090B | 11.77 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Accendra Health (ACH) | United States | $0.079B | 4.48 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.055B | 0.00 |
| Biote (BTMD) | United States | $0.049B | 3.97 |
| Nephros (NEPH) | United States | $0.046B | 38.46 |
| Veru (VERU) | United States | $0.041B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.036B | 17.21 |
| United-Guardian (UG) | United States | $0.033B | 13.39 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.023B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.018B | 0.00 |
| Modular Medical (MODD) | United States | $0.018B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |